Improvement in glucocorticoid-induced osteoporosis on switching from bisphosphonates to once-weekly teriparatide: a randomized open-label trial

HIGHLIGHTS

• who: Toshihiro Nanki and collaborators from the Division of Rheumatology, Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan have published the Article: Improvement in Glucocorticoid-Induced Osteoporosis on Switching from Bisphosphonates to Once-Weekly Teriparatide: A Randomized Open-Label Trial, in the Journal: (JOURNAL) of 26/Dec/2022
• what: The current study, designed to imitate real-world clinical practice, aimed to assess the effect of switching to weekly teriparatide on this patient population. Of note, the most significant difference between this study and the TOWER and TOWER-GO studies was that patients . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.